Elbanizine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C26H31N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S39YD087F9, chemically known as 1-(2-((2,6-dimethyl-3-nitro-4-pyridyl)amino)ethyl)-4-(diphenylmethyl)piperazine. but generally known as elbanizine, which bears US NIH Compound Identifier 208913. European Medicines Agency schedules Elbanizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06478MIG. The term ELBANIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). ELBANIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule elbanizine under HS 29335995 and SITC 51576. As of Q4 2014, ELBANIZINE remains the US FDA Preferred Term for this commodity. Elbanizine bears US NLM identifiers UMLS ID C2348394 and NCI Concept Code C73050. SMILES: O[N](=O)C1C(NCCN2CCN(CC2)C(C2CCCCC2)C2CCCCC2)CC(NC1C)C.